These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2188647)

  • 1. Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes.
    Wadsworth JD; Desai M; Tranter HS; King HJ; Hambleton P; Melling J; Dolly JO; Shone CC
    Biochem J; 1990 May; 268(1):123-8. PubMed ID: 2188647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes.
    Evans DM; Williams RS; Shone CC; Hambleton P; Melling J; Dolly JO
    Eur J Biochem; 1986 Jan; 154(2):409-16. PubMed ID: 3753681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of sites for 125I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomes.
    Dolly JO; Williams RS; Black JD; Tse CK; Hambleton P; Melling J
    Toxicon; 1982; 20(1):141-8. PubMed ID: 7043781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of a protease-sensitive acceptor component in mouse brain synaptosomes for Clostridium botulinum type B neurotoxin.
    Ogasawara J; Kamata Y; Sakaguchi G; Kozaki S
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):351-5. PubMed ID: 2060767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of Clostridium botulinum neurotoxin to the presynaptic membrane in the central nervous system.
    Hirokawa N; Kitamura M
    J Cell Biol; 1979 Apr; 81(1):43-9. PubMed ID: 383721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity.
    Shone CC; Hambleton P; Melling J
    Eur J Biochem; 1985 Aug; 151(1):75-82. PubMed ID: 3896784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin.
    Kamata Y; Kimura Y; Hiroi T; Sakaguchi G; Kozaki S
    Biochim Biophys Acta; 1993 Feb; 1156(2):213-8. PubMed ID: 8427878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes.
    Williams RS; Tse CK; Dolly JO; Hambleton P; Melling J
    Eur J Biochem; 1983 Mar; 131(2):437-45. PubMed ID: 6339240
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes.
    Murayama S; Syuto B; Oguma K; Iida H; Kubo S
    Eur J Biochem; 1984 Aug; 142(3):487-92. PubMed ID: 6468375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of Clostridium botulinum type C neurotoxin to rat brain synaptosomes.
    Agui T; Syuto B; Oguma K; Iida H; Kubo S
    J Biochem; 1983 Aug; 94(2):521-7. PubMed ID: 6630172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of botulinum neurotoxin to pure cholinergic nerve terminals isolated from the electric organ of Torpedo.
    Blasi J; Egea G; Castiella MJ; Arribas M; Solsona C; Richardson PJ; Marsal J
    J Neural Transm Gen Sect; 1992; 90(2):87-102. PubMed ID: 1334417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord.
    Habermann E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(1):47-56. PubMed ID: 4273827
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay.
    Li L; Singh BR
    J Nat Toxins; 1998 Oct; 7(3):215-26. PubMed ID: 9783260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.
    Kozaki S; Miki A; Kamata Y; Ogasawara J; Sakaguchi G
    Infect Immun; 1989 Sep; 57(9):2634-9. PubMed ID: 2668181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding ability of Clostridium botulinum neurotoxin to the synaptosome upon treatment of various kinds of the enzymes.
    Kitamura M; Sone S
    Biochem Biophys Res Commun; 1987 Mar; 143(3):928-33. PubMed ID: 3566763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes.
    Ashton AC; Dolly JO
    J Neurochem; 1988 Jun; 50(6):1808-16. PubMed ID: 2897427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative molecular topography of botulinum neurotoxins from Clostridium butyricum and Clostridium botulinum type E.
    Singh BR; Giménez JA; DasGupta BR
    Biochim Biophys Acta; 1991 Mar; 1077(1):119-26. PubMed ID: 1901221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive and useful radioimmunoassay for neurotoxin and its haemagglutinin complex from Clostridium botulinum.
    Ashton AC; Crowther JS; Dolly JO
    Toxicon; 1985; 23(2):235-46. PubMed ID: 3895579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.
    Kozaki S; Kamata Y; Nishiki T; Kakinuma H; Maruyama H; Takahashi H; Karasawa T; Yamakawa K; Nakamura S
    Infect Immun; 1998 Oct; 66(10):4811-6. PubMed ID: 9746583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism underlying the protective effect of the thearubigin fraction of black tea (Camellia sinensis) extract against the neuromuscular blocking action of botulinum neurotoxins.
    Satoh E; Ishii T; Shimizu Y; Sawamura S; Nishimura M
    Pharmacol Toxicol; 2002 Apr; 90(4):199-202. PubMed ID: 12076314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.